A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer

IsraelRecruiting

Conditions

Non-metastatic Prostate Cancer · Locally Recurrent Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

RAMBAM Health Care Campus, Haifa, Israel
Contact: Study coordinator (Tomer Charas, MD) · t_charas@rambam.health.gov.il · +972502062073
Contact: Study coordinator (Guy Froumin) · g_froumin@rambam.health.gov.il

Study leads

Tomer Charas, MD
Principal Investigator
Radiotherapy unit at Rambam Health Care Campus, Israel

View source on ClinicalTrials.gov Contact study team (email)